-
Application of Novel PACS-based Informatics Platform to Identify Imaging Based Predictors of CDKN2A Allelic Status in Glioblastomas
Authors:
Niklas Tillmanns,
Jan Lost,
Joanna Tabor,
Sagar Vasandani,
Shaurey Vetsa,
Neelan Marianayagam,
Kanat Yalcin,
E. Zeynep Erson-Omay,
Marc von Reppert,
Leon Jekel,
Sara Merkaj,
Divya Ramakrishnan,
Arman Avesta,
Irene Dixe de Oliveira Santo,
Lan Jin,
Anita Huttner,
Khaled Bousabarah,
Ichiro Ikuta,
MingDe Lin,
Sanjay Aneja,
Bernd Turowski,
Mariam Aboian,
Jennifer Moliterno
Abstract:
Gliomas with CDKN2A mutations are known to have worse prognosis but imaging features of these gliomas are unknown. Our goal is to identify CDKN2A specific qualitative imaging biomarkers in glioblastomas using a new informatics workflow that enables rapid analysis of qualitative imaging features with Visually AcceSAble Rembrandtr Images (VASARI) for large datasets in PACS. Sixty nine patients under…
▽ More
Gliomas with CDKN2A mutations are known to have worse prognosis but imaging features of these gliomas are unknown. Our goal is to identify CDKN2A specific qualitative imaging biomarkers in glioblastomas using a new informatics workflow that enables rapid analysis of qualitative imaging features with Visually AcceSAble Rembrandtr Images (VASARI) for large datasets in PACS. Sixty nine patients undergoing GBM resection with CDKN2A status determined by whole-exome sequencing were included. GBMs on magnetic resonance images were automatically 3D segmented using deep learning algorithms incorporated within PACS. VASARI features were assessed using FHIR forms integrated within PACS. GBMs without CDKN2A alterations were significantly larger (64% vs. 30%, p=0.007) compared to tumors with homozygous deletion (HOMDEL) and heterozygous loss (HETLOSS). Lesions larger than 8 cm were four times more likely to have no CDKN2A alteration (OR: 4.3; 95% CI:1.5-12.1; p<0.001). We developed a novel integrated PACS informatics platform for the assessment of GBM molecular subtypes and show that tumors with HOMDEL are more likely to have radiographic evidence of pial invasion and less likely to have deep white matter invasion or subependymal invasion. These imaging features may allow noninvasive identification of CDKN2A allele status.
△ Less
Submitted 18 September, 2023;
originally announced September 2023.
-
ChiENN: Embracing Molecular Chirality with Graph Neural Networks
Authors:
Piotr Gaiński,
Michał Koziarski,
Jacek Tabor,
Marek Śmieja
Abstract:
Graph Neural Networks (GNNs) play a fundamental role in many deep learning problems, in particular in cheminformatics. However, typical GNNs cannot capture the concept of chirality, which means they do not distinguish between the 3D graph of a chemical compound and its mirror image (enantiomer). The ability to distinguish between enantiomers is important especially in drug discovery because enanti…
▽ More
Graph Neural Networks (GNNs) play a fundamental role in many deep learning problems, in particular in cheminformatics. However, typical GNNs cannot capture the concept of chirality, which means they do not distinguish between the 3D graph of a chemical compound and its mirror image (enantiomer). The ability to distinguish between enantiomers is important especially in drug discovery because enantiomers can have very distinct biochemical properties. In this paper, we propose a theoretically justified message-passing scheme, which makes GNNs sensitive to the order of node neighbors. We apply that general concept in the context of molecular chirality to construct Chiral Edge Neural Network (ChiENN) layer which can be appended to any GNN model to enable chirality-awareness. Our experiments show that adding ChiENN layers to a GNN outperforms current state-of-the-art methods in chiral-sensitive molecular property prediction tasks.
△ Less
Submitted 10 July, 2023; v1 submitted 5 July, 2023;
originally announced July 2023.
-
Coherent Control of Optogenetic Switching by Stimulated Depletion Quenching
Authors:
Zachary Quine,
Alexei Goun,
Karl Gerhardt,
Jeffrey Tabor,
Herschel Rabitz
Abstract:
Optogenetics is a revolutionary new field of biotechnology, achieving optical control over biological functions in living cells by genetically inserting light sensitive proteins into cellular signaling pathways. Applications of optogenetic switches are expanding rapidly, but the technique is hampered by spectral cross-talk: the broad absorption spectra of compatible biochemical chromophores limits…
▽ More
Optogenetics is a revolutionary new field of biotechnology, achieving optical control over biological functions in living cells by genetically inserting light sensitive proteins into cellular signaling pathways. Applications of optogenetic switches are expanding rapidly, but the technique is hampered by spectral cross-talk: the broad absorption spectra of compatible biochemical chromophores limits the number of switches that can be independently controlled and restricts the dynamic range of each switch. In the present work we develop and implement a non-linear optical photoswitching capability, Stimulated Depletion Quenching (SDQ), is used to overcome spectral cross-talk by exploiting the molecules' unique dynamic response to ultrashort laser pulses. SDQ is employed to enhance the control of Cph8, a photo-reversible phytochrome based optogenetic switch designed to control gene expression in E. Coli bacteria. The Cph8 switch can not be fully converted to it's biologically inactive state ($P_{FR}$) by linear photos-witching, as spectral cross-talk causes a reverse photoswitching reaction to revert to it back to the active state ($P_{R}$). SDQ selectively halts this reverse reaction while allowing the forward reaction to proceed. The results of this proof of concept experiment lay the foundation for future experiments that will use optimal pulse shaping to further enhance control of Cph8 and enable simultaneous, multiplexed control of multiple optogenetic switches.
△ Less
Submitted 26 October, 2018;
originally announced October 2018.
